The Nogo receptor complex: confining molecules to molecular mechanisms

Trends in Molecular Medicine

Volumn 12, Issue 7, 2006, Pages 293-297

  Schwab, Jan M ^a,d   Tuli, Sagun K ^b   Failli, Vieri ^c  

^a CNRS   (France)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Wings for Life Spinal Cord Research Foundation   (Austria)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MYELIN; NOGO 66 RECEPTOR; PROTEIN; PROTEIN LINGO 1; PROTEIN P75; PROTEIN TROY; UNCLASSIFIED DRUG;

CENTRAL NERVOUS SYSTEM; GROWTH INHIBITION; NERVE FIBER GROWTH; NONHUMAN; PROTEIN DEGRADATION; SHORT SURVEY;

AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; ASPARTIC ENDOPEPTIDASES; AXONS; ENDOPEPTIDASES; HUMANS; MEMBRANE PROTEINS; MYELIN PROTEINS; MYELIN SHEATH; NERVE REGENERATION; NERVE TISSUE PROTEINS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CELL SURFACE; RECEPTORS, NERVE GROWTH FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR; SECOND MESSENGER SYSTEMS; SIGNAL TRANSDUCTION;

EID: 33746220096     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2006.05.001     Document Type: Short Survey

References (29)

1. Schwab M.E., and Caroni P. Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J. Neurosci. 8 (1988) 2381-2393
2. Filbin M.T. Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat. Rev. Neurosci. 4 (2003) 703-713
3. Oertle T., et al. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J. Neurosci. 23 (2003) 5393-5406
4. Fournier A.E., et al. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409 (2001) 341-346
5. Barton W.A., et al. Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J. 22 (2003) 3291-3302
6. Venkatesh K., et al. The Nogo-66 receptor homolog NgR2 is a sialic acid-dependent receptor selective for myelin-associated glycoprotein. J. Neurosci. 25 (2005) 808-822
7. Dodd D.A., et al. Nogo-A, -B, and -C are found on the cell surface and interact together in many different cell types. J. Biol. Chem. 280 (2005) 12494-12502
8. Hu F., et al. Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist. J. Neurosci. 25 (2005) 5298-5304
9. Lee D.H., et al. Targeting the Nogo receptor to treat central nervous system injuries. Nat. Rev. Drug Discov. 2 (2003) 872-878
10. Moreau-Fauvarque C., et al. The transmembrane semaphorin Sema4D/CD100, an inhibitor of axonal growth, is expressed on oligodendrocytes and upregulated after CNS lesion. J. Neurosci. 23 (2003) 9229-9239
11. Benson M.D., et al. Ephrin-B3 is a myelin-based inhibitor of neurite outgrowth. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 10694-10699
12. Hata K., et al. RGMa inhibition promotes axonal growth and recovery after spinal cord injury. J. Cell Biol. 173 (2006) 47-58
13. Mi S., et al. LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat. Neurosci. 7 (2004) 221-228
14. Park J.B., et al. A TNF receptor family member, TROY, is a coreceptor with Nogo receptor in mediating the inhibitory activity of myelin inhibitors. Neuron 45 (2005) 345-351
15. Shao Z., et al. TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 45 (2005) 353-359
16. Zheng B., et al. Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 1205-1210
17. Kim J.E., et al. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 44 (2004) 439-451
18. Ribotta M.G., et al. Activation of locomotion in adult chronic spinal rats is achieved by transplantation of embryonic raphe cells reinnervating a precise lumbar level. J. Neurosci. 20 (2000) 5144-5152
19. Woolf C.J., and Bloechlinger S. Neuroscience. It takes more than two to Nogo. Science 297 (2002) 1132-1134
20. Song X.Y., et al. Suppression of p75NTR does not promote regeneration of injured spinal cord in mice. J. Neurosci. 24 (2004) 542-546
21. Domeniconi M., et al. MAG induces regulated intramembrane proteolysis of the p75 neurotrophin receptor to inhibit neurite outgrowth. Neuron 46 (2005) 849-855
22. Esler W.P., and Wolfe M.S. A portrait of Alzheimer secretases - new features and familiar faces. Science 293 (2001) 1449-1454
23. Tanzi R.E., and Bertram L. Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell 120 (2005) 545-555
24. Sabo S.L., et al. The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J. Neurosci. 23 (2003) 5407-5415
25. Ahlgren S., et al. Accumulation of β-amyloid precursor protein and ubiquitin in axons after spinal cord trauma in humans: immunohistochemical observations on autopsy material. Acta Neuropathol. (Berl.) 92 (1996) 49-55
26. Koprivica V., et al. EGFR activation mediates inhibition of axon regeneration by myelin and chondroitin sulfate proteoglycans. Science 310 (2005) 106-110
27. Eguchi S., et al. Calcium-dependent epidermal growth factor receptor transactivation mediates the angiotensin II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells. J. Biol. Chem. 273 (1998) 8890-8896
28. Verma P., et al. Axonal protein synthesis and degradation are necessary for efficient growth cone regeneration. J. Neurosci. 25 (2005) 331-342
29. Schwab J.M., et al. Injury-related dynamic myelin/oligodendrocyte axon-outgrowth inhibition in the central nervous system. Lancet 365 (2005) 2055-2057